Seascape Capital Management’s Pfizer PFE Stock Holding History

Seascape Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,480	Closed	-$383K	–	99
2022 Q4	$383K	Sell	7,480 -1,643	-18%	-$78.8K	0.21%	80
2022 Q3	$399K	Sell	9,123 -573	-6%	-$27.8K	0.27%	70
2022 Q2	$508K	Buy	9,696 +5,188	+115%	+$264K	0.31%	64
2022 Q1	$233K	Buy	4,508 +82	+2%	+$4.25K	0.12%	81
2021 Q4	$261K	Buy	+4,426	New	+$219K	0.12%	82
2020 Q2	–	Sell	-12,407	Closed	-$384K	–	71
2020 Q1	$384K	Buy	12,407 +6,641	+115%	+$226K	0.35%	52
2019 Q4	$214K	Buy	+5,766	New	+$205K	0.15%	68

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Seascape Capital Management's PFE Position: Q1 2023 in Review

Seascape Capital Management sold out of Pfizer (PFE) in Q1 2023, closing a stake of 7,480 shares — an estimated $383K sold.

Seascape Capital Management first reported a position in PFE in Q4 2019 and held it in 7 quarters. The position peaked at $508K in Q2 2022. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

Seascape Capital Management reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
Seascape Capital Management sold 7,480 Pfizer shares in Q1 2023, an estimated $383K.
Seascape Capital Management first reported a position in Pfizer in Q4 2019 and held it in 7 quarters.
Seascape Capital Management's Pfizer position peaked at $508K in Q2 2022.
3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Seascape Capital Management's 13F filing for Q1 2023, filed 1 May 2023.